Literature DB >> 33078349

STK4 Deficiency Impairs Innate Immunity and Interferon Production Through Negative Regulation of TBK1-IRF3 Signaling.

Sofie E Jørgensen1,2, Ali Al-Mousawi1,2, Kristian Assing3, Ulla Hartling4, Dorthe Grosen4, Niels Fisker4, Christian Nielsen3, Marianne A Jakobsen3, Trine H Mogensen5,6,7.   

Abstract

BACKGROUND: STK4 deficiency due to homozygous mutations in the STK4 gene encoding the STK4/MST1 kinase was first described in 2012. STK4/MST1 kinase regulates cell proliferation, survival, differentiation, and immune responses through canonical and non-canonical Hippo signaling pathways.
OBJECTIVE: We describe an 11-year-old girl with a clinical presentation consisting of severe recurrent herpes zoster, chronic warts, and recurrent pneumonias, as well as a somatic phenotype with hypothyroidism and low stature. Whole exome sequencing revealed STK4 deficiency due to homozygosity for a novel frameshift variant in STK4, c.523dupA, p.(L174fsTer45), resulting in a premature stop codon within the kinase domain.
METHODS: We performed a thorough investigation of the genetics and innate and adaptive immunological abnormalities in STK4 deficiency.
RESULTS: We show significantly impaired type I, II, and III interferon (IFN) responses and partly reduced proinflammatory cytokine responses to ligands of Toll-like receptor (TLR)3, TLR9, and the cytosolic RNA and DNA sensors as well as to microorganisms. Impaired IFN responses could be attributed to reduced phosphorylation of TBK1 and IRF3. Moreover, virus infection induced enhanced cell death by apoptosis. Importantly, autophagy pathways were slightly disturbed, with enhanced LC3B-Ito LCB3-II conversion at the single cell level but normal overall formation of LCB3 punctae. Finally, the patient displayed some indicators of impaired adaptive immunity in the form of insufficient vaccination responses, T cell lymphopenia, and reduced Treg fractions, although with largely normal T cell proliferation and normal IFNg production.
CONCLUSION: Here, we demonstrate disturbances in various immune cell populations and pathways involved in innate immune responses, cell death, autophagy, and adaptive immunity in a patient homozygous for a novel STK4 frameshift mutation.

Entities:  

Keywords:  Autophagy; IRF3; Interferon; MST1; Oxidative burst; STK4; T cell lymphopenia; TBK1; Tregs

Mesh:

Substances:

Year:  2020        PMID: 33078349     DOI: 10.1007/s10875-020-00891-7

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  1 in total

1.  Impaired immune responses to herpesviruses and microbial ligands in patients with MonoMAC.

Authors:  Maibritt Mardahl; Sofie Eg Jørgensen; Alon Schneider; Klas Raaschou-Jensen; Mette Holm; Jens Veirum; Thomas K Kristensen; Isik S Johansen; Mette Christiansen; Kristian Assing; Trine H Mogensen
Journal:  Br J Haematol       Date:  2019-05-20       Impact factor: 6.998

  1 in total
  3 in total

Review 1.  Role of MST1 in the regulation of autophagy and mitophagy: implications for aging-related diseases.

Authors:  Huayu Shang; Trisha A VanDusseldorp; Ranggui Ma; Yan Zhao; Jason Cholewa; Nelo Eidy Zanchi; Zhi Xia
Journal:  J Physiol Biochem       Date:  2022-06-21       Impact factor: 4.158

2.  Differentially expressed microRNAs during the differentiation of muscle-derived stem cells into insulin-producing cells, a promoting role of microRNA-708-5p/STK4 axis.

Authors:  Yu Ren; Xiao Wang; Hongyu Liang; Yuzhen Ma
Journal:  PLoS One       Date:  2022-04-08       Impact factor: 3.240

3.  A Novel STK4 Mutation Impairs T Cell Immunity Through Dysregulation of Cytokine-Induced Adhesion and Chemotaxis Genes.

Authors:  Andrea Guennoun; Salim Bougarn; Taushif Khan; Rafah Mackeh; Mahbuba Rahman; Fatima Al-Ali; Manar Ata; Waleed Aamer; Debra Prosser; Tanwir Habib; Evonne Chin-Smith; Khawla Al-Darwish; Qian Zhang; Alya Al-Shakaki; Amal Robay; Ronald G Crystal; Khalid Fakhro; Amal Al-Naimi; Eman Al Maslamani; Amjad Tuffaha; Ibrahim Janahi; Mohammad Janahi; Donald R Love; Mohammed Yousuf Karim; Bernice Lo; Amel Hassan; Mehdi Adeli; Nico Marr
Journal:  J Clin Immunol       Date:  2021-08-24       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.